Anti-angiogenesis: making the tumor vulnerable to the immune system

Area of Science:

• Immunology
• Oncology
• Vascular Biology

Background:

• Ongoing angiogenesis contributes to immune suppression via mechanisms like reduced adhesion molecule expression on vascular endothelium.
• Tumor endothelium's altered adhesion molecules facilitate immune evasion and support tumor growth.
• Angiogenesis inhibition is hypothesized to counteract this immune suppressive effect.

Purpose of the Study:

• To investigate whether inhibiting angiogenesis can restore immune cell interactions with tumor vasculature.
• To determine if angiogenesis inhibitors can enhance anti-tumor immunity and facilitate immunotherapy.

Main Methods:

• In vitro and in vivo studies were conducted.
• The effects of various angiogenesis inhibitors on endothelial adhesion molecule expression were assessed.
• Leukocyte-endothelium interactions and inflammatory infiltrate in tumors were analyzed.

Main Results:

• Angiogenesis inhibitors normalized endothelial adhesion molecule expression in tumor blood vessels.
• Restoration of leukocyte-vessel wall interactions was observed.
• Enhanced inflammatory infiltrate within tumors was detected.

Conclusions:

• Inhibition of angiogenesis can reverse immune suppressive effects associated with tumor vasculature.
• Angiogenesis inhibitors may re-sensitize tumors to the immune system.
• These inhibitors show potential as adjuncts to facilitate cancer immunotherapy approaches.